Dr. Judy Laura-ann Ward, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6280 Sunset Dr Ste 400, South Miami, FL 33143 Phone: 305-662-4111 Fax: 305-662-5800 |
Dr. Rafael David Gottenger, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7330 Sw 62nd Pl, Suite #205, South Miami, FL 33143 Phone: 305-669-0900 Fax: 305-669-0100 |
Dr. Brad Herman, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6141 Sunset Dr, South Miami, FL 33143 Phone: 305-508-7035 Fax: 305-595-6491 |
Dr. Max L Polo, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 6280 Sunset Dr, Suite 501, South Miami, FL 33143 Phone: 305-666-1352 Fax: 305-667-8709 |
Dr. Jhonny Abraham Salomon, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6705 Sw 57th Ave, Suite 708, South Miami, FL 33143 Phone: 305-270-1361 Fax: 305-270-9138 |
Dr. Jose Miguel Soler-baillo Ii, M.D., M.S. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 7231 Sw 63rd Ave, 2nd Floor, South Miami, FL 33143 Phone: 305-661-1996 Fax: 305-662-2204 |
Dr. Sean Adam Simon, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6200 Sunset Dr, Suite 501, South Miami, FL 33143 Phone: 305-668-0496 Fax: 305-667-7459 |
Dr. Joseph W Michienzi, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6705 S Red Rd Ste 418, South Miami, FL 33143 Phone: 305-669-4426 |
Dr. Silvia Cristina Rotemberg, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7300 Sw 62nd Pl, Suite 200, South Miami, FL 33143 Phone: 305-669-0184 Fax: 305-669-0720 |
News Archive
RegeneRx Biopharmaceuticals, Inc. has announced that researchers have found that Thymosin beta 4 (Tβ4), in a dose dependent manner, stimulates oligodendrogenesis, the process by which central nervous system progenitor cells become oligodendrocytes that secrete myelin, the covering of nerve fibers.
ImmunoCellular Therapeutics today announced that it has entered into an agreement with the University of Pennsylvania under which University of Pennsylvania has granted the Company an exclusive, worldwide license for a patent pending technology for the production of high-activity dendritic cells.
Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. Understanding this mechanism of action may allow researchers to intervene prior to disease progression.
Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique platform technology, ZYOG1 is a novel, oral, anti-diabetic molecule.
› Verified 9 days ago